NCT01774825View on ClinicalTrials.gov

IQP-CL-101 in IBS Management

PHASE3CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

February 28, 2014

Study Completion Date

February 28, 2014

Conditions
Irritable Bowel Syndrome
Interventions
DIETARY_SUPPLEMENT

IQP-CL-101

2 softgels twice a day

OTHER

Placebo

2 softgels twice a day

Trial Locations (1)

10709

Barbara Grube, Berlin

Sponsors

Lead Sponsor

InQpharm Group
All Listed Sponsors
lead

InQpharm Group

INDUSTRY

NCT01774825 - IQP-CL-101 in IBS Management | Biotech Hunter | Biotech Hunter